MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

nice low volume bounce., page-2

  1. TDF
    102 Posts.
    With respect to the proposed listing on the NASDAQ, and associated issue of shares.

    Has anyone an idea on what price the new shares could be priced at? The past two lots were priced at a good discount to the market.

    Methinks the next issue will raise funds not just for research but also for building the production facility, so there could be a larger issue than the past two lots.


    TDF
 
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.